CODI Post Congress Symposium Series – Supported by Novo Nordisk
DIABETES SYMPOSIUM – February 28, 2024
Moderator: Itamar Raz, Israel
18:30-18:40 – Residual Cardiovascular Risk in Type 2 Diabetes
Hilla Knobler, Israel
18:40-18:50 – The Cardio Renal Metabolic approach should we treat to prevent
Baruch Itzhak, Israel
18:50-19:00 – Brain Health & Diabetes
Tali Cukierman-Yaffe, Israel
19:00-19:15 – When it comes to Diabetes time is running out
Stefano Del Prato, Italy
19:15-19:45 – Panel discussion
OBESITY SYMPOSIUM – February 28, 2024
Moderator: Itamar Raz, Israel
20:30-20:45 Semaglutide 2.4mg for Obesity – what is the MoA?
Dror Dicker, Israel
20:45-21:00 Semaglutide 2.4mg for the treatment of Obesity- Beyond Weight Loss
Idit Dotan, Israel
21:00-21:30 Panel discussion
DIABETES SYMPOSIUM – Wednesday April 3, 2024
Moderator: Itamar Raz, Israel
20:00-20:15 – T1D clinics in the primary care set up
Dr. Eitan Roitman
20:15-20:30 – Emerging treatments in pre GDM
Dr. Yoel Toledano
20:30-21:00 – Q&A panel discussion